Lung Cancer Profiling Panel - Liquid biopsy
Explore detailed information about this diagnostic testTest Information
Name: Lung Cancer Profiling Panel - Liquid biopsy
Code: G5641-AN
Sample Type: Liquid biopsy
Turnaround Time (TAT): 16 days
Preparation & Notes
16ml Liquid biopsy (cfDNA) is a next generation sequencing (NGS) based test designed to empower personalized treatment decisions in patients with lung cancer microsatellite instability (MSI) . The detection is based on DNA, and utlizes unique molecular barcode (UMI) for digital error correction with limit of detection equal to 0.1% allele frequency .